Tinnitus affects 740 million people worldwide, yet sufferers still face a critical lack of practical, 24/7 relief options.
British health tech company TinniSoothe has developed the world’s first wearable sound therapy device to provide round the clock relief, without the need for anything in or around the ears. They are currently doing their first equity raise on CrowdCube, where it is now overfunding, following strong early interest.
Founded by tinnitus sufferer Howard Presland, TinniSoothe was created to solve a problem existing technologies have long overlooked. Traditional solutions such as hearing aids, earbuds, and external devices are either intrusive, impractical for all-day use, or ineffective at night when tinnitus can be most acute.
TinniSoothe’s patented, neck-worn device emits a continuous stream of subtle white noise towards the ears, designed to distract the brain and accelerate habituation, the process of reclassifying tinnitus as an unimportant background sound. Users can easily personalise volume and frequency settings, and the device automatically switches to night-time mode when docked, offering seamless day-to-night support. The docking cradle also recharges the battery so that the wearable module is ready for the next day.
Registered as a Class 1 Medical Device and proudly Made in Britain, TinniSoothe represents a scalable, consumer-friendly solution in a rapidly growing market. The tinnitus devices market is forecast to exceed $3.5 billion by 2030, driven by rising noise pollution, ageing populations and over-use of noise-cancelling headphones.
TinniSoothe has just completed its first full year of trading with statutory accounts currently pending for March 31, 2025. Provisional numbers show Income already approaching six figures, largely from initial eCommerce sales from tinnisoothe.com.
With excellent user reviews and the concept now proved, the team is accelerating its Go-To-Market strategy in other channels, under the experienced leadership of B2B revenue growth expert, Jez Lawson.
TinniSoothe addresses a major gap: the need for discreet, continuous relief without compromising user lifestyle. Its simple, wearable design and potential as a broader platform play, position the company for channel growth in direct-to-consumer, retail hearingcare and national health system markets.
With its protected IP, a compelling founder story, and first-mover advantage in a largely untapped segment, TinniSoothe offers investors a unique opportunity to back a visionary team and a product with significant clinical need, high consumer demand, and strong potential for global scalability.